PHIO icon

Phio Pharmaceuticals

17 hedge funds and large institutions have $591K invested in Phio Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
3
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
CH
1
CVI Holdings
Delaware
$272K 604,939 +449,804 +290%
VF
2
Virtu Financial
New York
$107K 238,544 +238,544 New
SG Americas Securities
3
SG Americas Securities
New York
$103K 228,825 +65,095 +40%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$45K 98,997 +98,997 New
Citadel Advisors
5
Citadel Advisors
Florida
$15K 34,405 +14,519 +73%
TSS
6
Two Sigma Securities
New York
$15K 32,450 +32,450 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$12K 26,460
UBS Group
8
UBS Group
Switzerland
$11K 23,873 +23,873 New
Renaissance Technologies
9
Renaissance Technologies
New York
$5K 11,277 +11,277 New
Morgan Stanley
10
Morgan Stanley
New York
$3K 5,718
Deutsche Bank
11
Deutsche Bank
Germany
$3K 7,800 +7,800 New
KFS
12
Kelly Financial Services
Massachusetts
$2 5 +5 New
SM
13
Sabby Management
Florida
-1,575,157 Closed
EDRH
14
Edmond de Rothschild Holding
Switzerland
-10,790 Closed
CA
15
Claro Advisors
Massachusetts
-378 Closed
BDWM
16
Brewin Dolphin Wealth Management
Ireland
-1 Closed
BlackRock
17
BlackRock
New York
$0 1,115
AG
18
Advisor Group
Arizona
$0 19
AWM
19
Aevitas Wealth Management
Massachusetts
$0 40
CFGS
20
Concourse Financial Group Securities
Alabama
Bank of America
21
Bank of America
North Carolina
$0 65
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$0 700